Michael E. Luggen
Impact in
- Rheumatology top 0.2%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
- Hematology top 2%
- Autoimmune and Inflammatory Disorders Research
Papers in
- Rheumatology 32
- Rheumatoid Arthritis Research and Therapies 14
- Systemic Lupus Erythematosus Research 12
- Spondyloarthritis Studies and Treatments 7
-
- Systemic Sclerosis and Related Diseases 6
- Co-authors
- Mark C. Genovese (3 shared papers)Maxime Dougados (3 shared papers)Jean‐Claude Becker (2 shared papers)Isaac F. Nuamah (2 shared papers)Richard Aranda (3 shared papers)Michael H. Schiff (2 shared papers)J. Box (2 shared papers)Tracy M.W.Y. Li (1 shared paper)
- Journals
- Annals of the Rheumatic Diseases (7 papers)The Journal of Rheumatology (3 papers)Lupus (2 papers)JAMA (2 papers)Clinical Rheumatology (2 papers)
- Partner nations
- United StatesAustriaUnited Kingdom
In The Last Decade
Michael E. Luggen
43 papers receiving 3.6k citations
Michael E. Luggen's Hit Papers
Peers
Comparison fields: 5 of 105
- Rheumatology 2.5k
- Hematology 699
- Immunology 976
- Genetics 317
- Pathology and Forensic Medicine 332
Countries citing papers authored by Michael E. Luggen
This map shows the geographic impact of Michael E. Luggen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Luggen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Luggen more than expected).
Fields of papers citing papers by Michael E. Luggen
This network shows the impact of papers produced by Michael E. Luggen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Luggen. The network helps show where Michael E. Luggen may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael E. Luggen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition Hit paper breakdown → | 2005 | 1019 |
| 2 | Comparison of low‐dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis. A Controlled Clinical Trial Hit paper breakdown → | 1985 | 408 |
| 3 | 1996 | 369 | |
| 4 | 2002 | 314 | |
| 5 | 2007 | 236 | |
| 6 | 2007 | 220 | |
| 7 | 1996 | 194 | |
| 8 | 1988 | 99 | |
| 9 | Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease. | 1991 | 78 |
| 10 | 1999 | 69 | |
| 11 | 2021 | 69 | |
| 12 | Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: open-label extension of a randomized, double-blind, placebo controlled trial. | 2004 | 67 |
| 13 | 2006 | 59 | |
| 14 | 2012 | 59 | |
| 15 | 1987 | 55 | |
| 16 | Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases. | 1991 | 55 |
| 17 | The evolution of Raynaud's phenomenon: a longterm prospective study. | 1995 | 53 |
| 18 | 2011 | 47 | |
| 19 | 2012 | 46 | |
| 20 | 1996 | 43 |
About Michael E. Luggen
Michael E. Luggen is a scholar working on Rheumatology, Pathology and Forensic Medicine, Immunology, Hematology and Nephrology, having authored 46 papers that have together received 3.9k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (14 papers), Systemic Lupus Erythematosus Research (12 papers), Spondyloarthritis Studies and Treatments (7 papers), Systemic Sclerosis and Related Diseases (6 papers), Autoimmune and Inflammatory Disorders Research (5 papers), Psoriasis: Treatment and Pathogenesis (4 papers), T-cell and B-cell Immunology (3 papers) and Inflammatory Myopathies and Dermatomyositis (3 papers). The work is most often cited by research in Rheumatology (2.5k citations), Hematology (699 citations), Immunology (976 citations), Genetics (317 citations) and Pathology and Forensic Medicine (332 citations). Michael E. Luggen has collaborated with scholars based in United States, Austria and United Kingdom. Frequent co-authors include Mark C. Genovese, Maxime Dougados, Jean‐Claude Becker, Isaac F. Nuamah, Richard Aranda, Michael H. Schiff, J. Box, Tracy M.W.Y. Li, Yvonne Sherrer and Charles A. Birbara. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Rheumatology, Lupus, JAMA and Clinical Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.